Skip to main content

Diabetes Masterclass Educational Series - CGM Interpretation - Clinical Case Scenarios

ABCD, YDEF and Lilly have partnered to provide a virtual education programme for specialists working in diabetes.

The Diabetes Masterclass Educational Series has been organised and funded by Eli Lilly & Company, developed in partnership with ABCD and YDEF.

The webinar series provides regular updates on relevant topics to support those delivering diabetes services. Watch the webinar on-demand below.

CGM Interpretation - Clinical Case Scenarios

 

Dr Tomás Griffin

Dr Tomás Griffin

Dr Tomás Griffin is a graduate of the school of Medicine at the National University of Ireland Galway (First Honour). In addition, he holds a Masters in Clinical Research (First Honour) and a Higher Diploma in Clinical Education from the National University of Ireland Galway. He is completing a PhD in the prevalence of Diabetic Kidney Disease and novel biomarkers that may predict decline in renal function.

Dr Griffin currently works as a Clinical Fellow in Diabetes Technology at Leicester General Hospital, as a Diabetes Fellow at the University of Leicester and as a Clinical Consultant in Diabetes Communication Technology at the University of Dundee. Dr Griffin was previously the clinical lead for the Insulin Pump/Technology services at Galway University Hospitals, Ireland. He currently is the local lead for the roll-out of the Hybrid Closed Loop Insulin Pump Pilot at Leicester General Hospital. In addition to multiple academic publications, Dr Griffin has received national and international awards for his research.

 

Nicola Taylor

Nicola Taylor

Nicola Taylor is an adult Diabetes Specialist Dietitian currently working at the University Hospitals of Derby and Burton. She is the Team Lead for the Diabetes Dietitians and the Insulin Pump and CGM Service Lead. Nicola’s main clinical interest is in the management and education of people with Type 1 diabetes and along with the team at UHDB offers a full range of treatments including structured education (DAFNE), technology including insulin pump therapy, sensor augmented pump therapy, hybrid closed loop systems, continuous glucose monitoring and flash glucose monitoring. She and her team have over 600 patients on insulin pumps and were the biggest centre providing hybrid closed loop systems as part of the NHS England pilot. Nicola’s passion is ensuring diabetes technology is accessible and helping people with diabetes to feel empowered to use this, to not only help improve diabetes control but quality of life too.


This content has been organised and funded by Eli Lilly & Company, developed in partnership with ABCD and YDEF.

Intended for Healthcare Professionals in the UK and Ireland

PP-LD-GB-1857 January 2023

© 2023 Eli Lilly and Company. All rights reserved.

Lilly is a registered trademark of Eli Lilly and Company

Resource taxonomy
Listing status